// App-Quantinova.ai

[THU0396] : THE EFFICACY OF HYDROXYCHLOROQUINE FOR OBSTETRICAL OUTCOME IN ANTI-PHOSPHOLIPID SYNDROME: DATA FROM A EUROPEAN MULTICENTER RETROSPECTIVE STUDY

Researchers

Presenter

  • A. Mekinian

Principal Investigators

  • A. Kuzenko

  • F. Maurier

  • L. Andreoli

  • A. Benbara

  • A. Tigaizin

  • L. Carbillon

  • P. Nicaise Roland

  • A. Tincani

  • O. Fain

  • J. Alijotas-Reig

  • A. Ruffatti

  • P. Levy

  • V. Canti

  • K. Bremme

  • H. Bezanahary

  • T. Bertero

  • R. Dhote

Medical Centers

  • Systemic Autoimmune Disease Unit, Barcelona, Spain

  • Department of Women's and Children's Health, Department of Women's and Children's Health, Stochkolm, Sweden

  • Istituto Scientifico Ospedale, Istituto Scientifico Ospedale, San Raffaele, Italy

  • Internal Medicine, DHUiB Saint Antoine Hospital, paris, France

  • Biostatistics, Tenon Hospital, Paris, France

  • Rheumatology, Padua Hospital, Padua, Italy

  • Clinical Immunology, Turin, Italy

  • Autoimmunity, Immunology, Paris, France

Locations

  • France

  • Spain

  • Italy

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Sjogren's syndrome

  • Preeclampsia

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Prednisone

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved